ROCKWELL MEDICAL, INC. Debt Instrument, Interest Rate, Effective Percentage
ROCKWELL MEDICAL, INC. (RMTI) had Debt Instrument, Interest Rate, Effective Percentage of 4.65% as of 2019-06-03, per its 10-Q filed 2020-05-11.
Discontinued › Notes › Debt Instruments
us-gaap:DebtInstrumentInterestRateEffectivePercentage · last filed 2020-05-11
- 2019-06-03: Debt Instrument, Interest Rate, Effective Percentage 4.65%.
| Period end | Debt Instrument, Interest Rate, Effective Percentage |
|---|---|
| 2019-06-03 | 4.65% 10-Q · filed 2020-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B |